Proquest Associates II LLC insider trades: Novadel Pharma (NVDL) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Proquest Associates II LLC reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 31, 2010 | NVDL | ↑ Buy | 4,848,485 | $0.17 | $800K | See | Apr 1, 2010 (1d) |
| Nov 29, 2005 | PTN | ↓ Sell | 358,000 | $3.92 | $1.4M | Direct | Dec 1, 2005 (2d) |
| Oct 28, 2005 | THLD | ↓ Sell | 55,182 | $10.46 | $577K | By each of ProQuest Associates II LLC, J | Oct 31, 2005 (3d) |
| Oct 28, 2005 | THLD | ↓ Sell | 55,182 | $10.46 | $577K | Direct | Oct 31, 2005 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Proquest Associates II LLC's insider trades
Proquest Associates II LLC is a 10% owner of Novadel Pharma (NVDL). Since Oct 28, 2005, it has reported 1 open-market purchase worth $800K and 3 sales worth $2.6M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (3 filings), option exercises (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NVDL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.